HTFL - Kewajiban jangka dawa marang modal HeartFlow Inc

HTFL (HeartFlow, Inc.) - tandha merek perusahaan

Heartflow Inc (HTFL) possesses significant pricing power over its services due to its proprietary software, allowing the company to pass development costs onto insurers. Business efficiency relies on the precision of AI algorithms and their recognition by insurance funds. This price chart on GURU.Markets, where the indicator stands at 0.07, reflects the price action of a leader in non-invasive 3D blood flow modeling.

HTFL - Utang jangka dawa marang ekuitas Heartflow Inc ing rentang 09.08.2025 - 27.10.2026

HTFL (HeartFlow Inc): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Bagan owah-owahan rega HeartFlow|HTFL - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar HeartFlow, Inc.|HTFL - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham HeartFlow|HTFL - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku heartflow.com|HTFL - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Utang Agregat marang Modal Heartflow Inc|HTFL - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal HeartFlow Corp|HTFL - Gunggung utang perusahaan|Utang-utang marang nilai buku HeartFlow, Inc.
Ringkesan analitik perusahaan:HTFL, Heartflow Inc
Barang utama HeartFlow Inc

Complex clinical trials and stringent FDA oversight require colossal investments from Heartflow Inc, making the current long-term debt-to-equity ratio a key indicator of financial stability. The value of 0.07 reflects the proportion of liabilities with a maturity exceeding one year relative to equity, allowing investors to assess the balance between debt-funded expansion in AI diagnostics and the risk of capital dilution.

Pesaing wigati

Koefisien utang jangka dawa marang modal Regeneron Pharmaceuticals, Inc.|iRhythm Technologies Inc - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Lantheus Corp (LNTH)|Utang jangka dawa marang modal MLYS (Mineralys Therapeutics)|kestramedical.com - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Esperion (ESPR)|Amarin Corporation (AMRN) - Koefisien utang jangka dawa marang modal|AVR - Rasio utang jangka dawa marang ekuitas|Tenaya Therapeutics, Inc. (TNYA) - Rasio silihan jangka dawa marang modal|CVRX - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal milestonepharma.com|Cardiol Therapeutics - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal HeartBeam Inc (BEAT)|Utang jangka dawa marang modal TENX (Tenax Therapeutics, Inc)|Adagio Medical, Inc. - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas BioCardia, Inc. (BCDA)|catheterprecision.com (VTAK) - Koefisien utang jangka dawa marang modal|ABIO - Rasio utang jangka dawa marang ekuitas|Acasti Pharma Inc. (ACST) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal Aerovate AVTE|Kewajiban jangka dawa marang ekuitas VERV|Utang jangka dawa marang ekuitas Windtree Therapeutics (WINT)